expertise, innovation, health
From the fundamental research to the delivery of innovative and trusted solutions,
we focus on 3 core activities:
Selected & advanced generics, Consumer health, and Original drugs.
• Niche molecules
• Hard-to-make drugs
• Innovative delivery forms to improve health daily practices.
Our Health Care Innovation range encompasses scientifically selected actives to always offer unique and natural formulas supported by clinically proven efficacy.
A WORLDWIDE PRESENCE
Our Swiss expertise and presence are continuously spread out around the world through dedicated affiliates and key partnerships in more than 60 countries.
STRAGEN specialized scientific team constantly operates under the latest quality standards to develop health solutions for tomorrow’s needs. In all we do, we strive to be innovative, reliable and passionate.
Being a STRAGEN partner means building a close and long-term collaboration and getting part of a dynamic and committed team!
OUR VISION OF PARTNERSHIP
CREATING NEW BUSINESS MODELS
Expanding our global reach
Building strong partnerships
IMPROVing YOUR COMMUNICATION
STRAGEN Vietnam will be the platinum sponsor of the biggest Gynecologist congress in Vietnam in November 2018 (HOSREM)
It is time for STRAGEN to enter in a new era!
Growing portfolio, rising customer expectations, new traceability requirements, permanent stimulation of innovation, search for new opportunities…
Alaxia moves forward its promising CF antimicrobial drug candidate at the North American Cystic Fibrosis Conference from October 18th-20th in Denver.
+41 22 799 19 19
STRAGEN PHARMA SA
Chemin du Pré-Fleuri 3